1-1 of 1
Emilie Asselberg-Hacker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation Phase 2 Trial Of Carfilzomib Combined With Thalidomide and Low-Dose Dexamethason In Newly Diagnosed, Transplant Eligible Patients With Multiple Myeloma. A Trial Of The European Myeloma Network

Pieter Sonneveld, MD, Ph.D, Emilie Asselberg-Hacker, Sonja Zweegman, MD PhD, Bronno van der Holt, Marie Jose Kersten, MD, PhD, Edo Vellenga, Marinus van Marwijk Kooy, MD, PhD, Okke de Weerdt, MD, Sarah Lonergan, MSc, Antonio Palumbo, MD, Henk Lokhorst
Journal: Blood
Blood (2013) 122 (21): 688.
https://doi.org/10.1182/blood.V122.21.688.688
Published: 2013